Cargando…

Testosterone therapy: a friend or a foe for the aging men with benign prostatic hyperplasia?

Detalles Bibliográficos
Autores principales:	Rastrelli, Giulia, Vignozzi, Linda, Maggi, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Invited Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275798/ https://www.ncbi.nlm.nih.gov/pubmed/31424029 http://dx.doi.org/10.4103/aja.aja_86_19

Ejemplares similares

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Benign Prostatic Hyperplasia: A New Metabolic Disease of the Aging Male and Its Correlation with Sexual Dysfunctions
por: Corona, Giovanni, et al.
Publicado: (2014)

Both comorbidity burden and low testosterone can explain symptoms and signs of testosterone deficiency in men consulting for sexual dysfunction
por: Rastrelli, Giulia, et al.
Publicado: (2019)

Testosterone does not affect lower urinary tract symptoms while improving markers of prostatitis in men with benign prostatic hyperplasia: a randomized clinical trial
por: Rastrelli, G., et al.
Publicado: (2022)

Glucocorticoids and prostate cancer treatment: friend or foe?
por: Montgomery, Bruce, et al.
Publicado: (2014)

Erectile dysfunction and central obesity: an Italian perspective
por: Corona, Giovanni, et al.
Publicado: (2014)

Diagnosis and treatment of benign prostate hyperplasia in Asia
por: Foo, Keong Tatt
Publicado: (2015)

Testosterone in COVID-19: Friend or Foe?
por: Niemann, Peter J., et al.
Publicado: (2021)

Podiatric surgery: friend or foe?
por: Prior, Trevor D
Publicado: (2011)

Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?
por: Crocombe, Dominic, et al.
Publicado: (2023)

Testosterone replacement therapy and the heart: friend, foe or bystander?
por: Lopez, David S., et al.
Publicado: (2016)

Role of Rezum in the treatment of benign prostate hyperplasia: A review of the literature
por: Cocci, Andrea, et al.
Publicado: (2021)

Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations
por: Morgentaler, Abraham, et al.
Publicado: (2015)

The emancipation of testosterone from niche hormone to multi-system player
por: Saad, Farid
Publicado: (2015)

Erectile Dysfunction Is a Hallmark of Cardiovascular Disease: Unavoidable Matter of Fact or Opportunity to Improve Men’s Health?
por: Yannas, Dimitri, et al.
Publicado: (2021)

What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)?
por: Foo, Keong Tatt
Publicado: (2019)

Berberine ameliorates testosterone-induced benign prostate hyperplasia in rats
por: Shabani, Ehsan, et al.
Publicado: (2021)

Testosterone Deficiency and Risk of Cognitive Disorders in Aging Males
por: Corona, Giovanni, et al.
Publicado: (2021)

The use of a single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunction
por: Gacci, Mauro, et al.
Publicado: (2013)

Intraoperative graft patency validation: Friend or foe?
por: Akhrass, Rami, et al.
Publicado: (2021)

Comparative application of testosterone undecanoate and/or testosterone propionate in induction of benign prostatic hyperplasia in Wistar rats
por: An, Jinho, et al.
Publicado: (2022)

The Effect of Xialiqi Capsule on Testosterone-Induced Benign Prostatic Hyperplasia in Rats
por: Cai, Hongcai, et al.
Publicado: (2018)

Inhibitory Effect of Astaxanthin on Testosterone-Induced Benign Prostatic Hyperplasia in Rats
por: Wang, Liping, et al.
Publicado: (2021)

Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia
por: De Nunzio, Cosimo, et al.
Publicado: (2020)

Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results
por: Kacker, Ravi, et al.
Publicado: (2016)

The role of the general practitioner in men's health
por: David, Janine
Publicado: (2019)

The relationship between sleep disorders and testosterone in men
por: Wittert, Gary
Publicado: (2014)

Inhibitory effect of curcumin on testosterone induced benign prostatic hyperplasia rat model
por: Kim, Su Kang, et al.
Publicado: (2015)

Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats
por: Al-Trad, Bahaa, et al.
Publicado: (2019)

Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats
por: Jeon, Woo-Young, et al.
Publicado: (2017)

Effects of Alginate Oligosaccharide on Testosterone-Induced Benign Prostatic Hyperplasia in Orchiectomized Rats
por: Jang, You-Jee, et al.
Publicado: (2023)

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia
por: Putra, Ida Bagus O.W., et al.
Publicado: (2016)

Therapy decisions for the symptomatic patient with metastatic castration-resistant prostate cancer
por: Markowski, Mark C, et al.
Publicado: (2015)

Testosterone Replacement Therapy and Cardiovascular Risk: A Review
por: Corona G, Giovanni, et al.
Publicado: (2015)

Corrigendum: Testosterone Replacement Therapy and Cardiovascular Risk: A Review
por: Corona, Giovanni, et al.
Publicado: (2016)

Optimal management of prostate cancer with lethal biology – state-of-the-art local therapy
por: Chapin, Brian F
Publicado: (2015)

The Xu's chart for prostate biopsy: a visual presentation of the added value of biomarkers to prostate-specific antigen for estimating detection rates of prostate cancer
por: Xu, Jianfeng
Publicado: (2014)

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)

Clinical correlates of enlarged prostate size in subjects with sexual dysfunction
por: Corona, Giovanni, et al.
Publicado: (2014)

The Human Microbiota and Prostate Cancer: Friend or Foe?
por: Massari, Francesco, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sotff52jcljsk3e6bnorudf1ik